Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership37,841 shares
Latest Disclosed Value $ 1,139,771
Engineers Gate Manager LP ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 37,841 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $1,139,771 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). The current value of the position is $1,242,320 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,841 37,841 1,140 0.0142
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -35,340 -100.00 0 -100.00
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 35,340 -70,355 -66.56 592 -63.55 0.0074
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 105,695 105,695 1,625 0.0274
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -50,157 -100.00 0 -100.00
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 50,157 26,015 107.76 904 130.36 0.0176
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 24,142 -35,627 -59.61 392 -53.50 0.0088
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 59,769 -29,693 -33.19 843 -9.65 0.0222
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 89,462 63,140 239.88 934 248.13 0.0267
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 26,322 -53,034 -66.83 268 -55.11 0.0099
2023-08-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 79,356 22,457 39.47 598 18.69 0.0226
2023-05-15 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 56,899 -17,126 -23.14 504 -25.48 0.0210
2023-02-14 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 74,025 59,220 400.00 675 467.23 0.0406
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 14,805 -17,295 -53.88 119 -50.62 0.0074
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 32,100 32,100 241 0.0088
2022-05-16 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -67,000 -100.00 0 -100.00
2022-02-14 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 67,000 56,600 544.23 537 431.68 0.0242
2021-11-15 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 10,400 10,400 101 0.0058
2021-08-16 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -27,960 -100.00 0 -100.00
2021-05-17 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 27,960 10,960 64.47 323 96.95 0.0160
2021-02-16 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 17,000 -17,900 -51.29 164 -47.77 0.0071
2020-11-16 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 34,900 -39,073 -52.82 314 -65.57 0.0147
2020-08-17 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 73,973 30,236 69.13 912 132.06 0.0464
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 43,737 -14,263 -24.59 393 -30.81 0.0283
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 58,000 42,900 284.11 568 446.15 0.0250
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,100 3,500 30.17 104 -2.80 0.0053
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 11,600 11,600 107 0.0059
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.